Ortho Clinical Diagnostics - a Johnson & Johnson Company.
Global Sites:  United Kingdom (English)
Skip navigation links
    
Solutions that drive knowledge. Solutions that drive knowledge.

Solutions that drive knowledge.

 Clinical Laboratories | VITROS® 5600 Integrated System

 

 

Menu

View full VITROS® Menu

Ortho Clinical Diagnostics is committed to constantly evaluating our assay portfolio to bring you a broad disease state menu that meets your testing needs and helps doctors and patients know more so treatment decisions can be made sooner.

Our menu covers 90% of the menu needs and 99% of the testing volume for typical labs with:

+  Over 120 available assays
+  10 user-defined chemistry channels
+  Wide accessible menu on-board at all times
+  Standardized reagents and results across all VITROS® platforms

World-class assays for quality results

VITROS® DAT Assays

Excellent correlation to EMIT® and greater precision increase confidence in patient results. Allows consolidation with routine chemistry.

VITROS® Troponin I ES Assay

Improved sensitivity delivers reliable information for patients with acute coronary syndrome. Meets ACC/ESC guideline for acceptable imprecision in a high sensitivity assay (10% CV at 99th percentile).

VITROS® NT-proBNP Assay

Provides confidence to physicians for the differential diagnosis of heart failure, improving patient care. Enables consolidated cardiac testing on one fully random-access system. Adopted in ESC/ACC/AHA practice guidelines.1,2

VITROS® d%A1C Assay

High-quality results with traceability to the NGSP and IFCC Standards. No manual pre-treatment

means fewer potential errors.

VITROS® Anti-HCV Assay

A version 3.0 fully automated, random-access diagnostic test for IgG antibody to hepatitis C virus. Provides improved sensitivity. Results in less than 60 minutes, available any time in any order.

VITROS®  Electrolytes (Na+, Cl- and K+)

World-class Direct Ion Selective Electrodes (ISEs) with true results regardless of dilution, interferents or presence of abnormal proteins or lipids—all with lower overall costs.

VITROS®  BuBc Assay

World-class Bilirubin results with direct BuBc measurement correlated to HPLC, high specificity and small sample volume, ideal for neonatal populations.


For information about the full menu for the VITROS® 5600 Integrated System, contact Ortho Clinical Diagnostics.

1. Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic
heart failure, European Society of Cardiology. Eur Heart Journal. 2001;22:1527-1560.

2. Hunt SA, Abraham WT, Chin MH, et al. ACC/AHA 2005 Guideline update for the
diagnosis and management of chronic heart failure in the adult. Circulation.
2005;112:
e154-e235.

 

Product availability subject to local regulatory requirements.

 


VITROS®  5600

This site is published by Ortho-Clinical Diagnostics, which is solely responsible for the content. Registered in England No: 2549777. © All contents copyright Ortho-Clinical Diagnostics, 2003-2011 unless otherwise noted. Product availability is subject to fulfillment of regulatory requirements in each market. This site was written for and is intended for Healthcare Professionals in the United Kingdom only. Last Modified Date:15/05/2012 14:53